(Q42527743)

1 November 2017

Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

1 November 2017

0 references

1 reference

1 reference

1 reference

1 reference

8

1 reference

1 November 2017

4

June Carnier

1 reference

1 November 2017

1

Lian Tock

1 reference

1 November 2017

Ana R Dâmaso

2

1 reference

1 November 2017

Aline de Piano

3

1 reference

1 November 2017

Priscila L Sanches

5

1 reference

1 November 2017

Henrique Manoel Lederman

6

1 reference

1 November 2017

Regina M Y Ernandes

7

1 reference

1 November 2017

Sérgio Tufik

9

1 reference

1 November 2017

9 February 2010

1 reference

1 November 2017

1 reference

1 November 2017

2010

1 reference

1 November 2017

5722-5725

1 reference

Creative Commons Attribution 3.0 Unported

1 November 2017

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Non-alcoholic fatty-liver disease in pediatric populations

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Review: The role of insulin resistance in nonalcoholic fatty liver disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Non-alcoholic fatty liver disease and insulin resistance.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Review article: Non-alcoholic fatty liver disease

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

CDC growth charts: United States

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Cardiovascular risk factors, their associations and presence of metabolic syndrome in adolescents

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Metformin in the treatment of patients with non-alcoholic steatohepatitis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Methods of estimation of visceral fat: advantages of ultrasonography.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Metformin: new understandings, new uses

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

The utility of radiological imaging in nonalcoholic fatty liver disease.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2925435

Nonalcoholic fatty liver disease decrease in obese adolescents after multidisciplinary therapy

16 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F831901

Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F831901

Metabolic and Nutritional Profile of Obese Adolescents With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2010%2F831901

Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20798858

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of type 2 diabetes mellitus in children and adolescents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20798858

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2010/831901

1 reference

1 November 2017

1 reference

1 November 2017

PubMed publication ID

20798858

1 reference